For: | Herold Z, Herold M, Lohinszky J, Szasz AM, Dank M, Somogyi A. Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer. World J Clin Cases 2022; 10(20): 6825-6844 [PMID: 36051133 DOI: 10.12998/wjcc.v10.i20.6825] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i20/6825.htm |
Number | Citing Articles |
1 |
Ralf Kleef, Magdolna Dank, Magdolna Herold, Emese Irma Agoston, Julia Lohinszky, Emoke Martinek, Zoltan Herold, Attila Marcell Szasz. Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47802-5
|
2 |
Eugeniy Smorodin, Valentin Chuzmarov, Toomas Veidebaum. The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. Current Oncology 2024; 31(4): 1994 doi: 10.3390/curroncol31040149
|
3 |
Alfonso Martín-Carnicero, Enrique Ramalle-Gomara, Susana Rubio-Mediavilla, Martina Alonso-Lago, Miriam Zorrilla-Larraga, Isabel Manrique-Abós, María E. de las Heras-Dueña, Ignacio M. Larrayoz, Alfredo Martínez. Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy. Journal of Clinical Medicine 2022; 11(20): 6091 doi: 10.3390/jcm11206091
|
4 |
Aleksandra Misiewicz, Violetta Dymicka-Piekarska. Fashionable, but What is Their Real Clinical Usefulness? NLR, LMR, and PLR as a Promising Indicator in Colorectal Cancer Prognosis: A Systematic Review. Journal of Inflammation Research 2023; : 69 doi: 10.2147/JIR.S391932
|
5 |
Pırıltı Özcan, Özgül Düzgün. The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis. Journal of Personalized Medicine 2024; 14(9): 916 doi: 10.3390/jpm14090916
|